Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Antisense compound targeting cholesterol reported

Jan. 29, 1997

MK-677 enhances GH activity in the elderly

Jan. 29, 1997

TKT product advances toward the clinic

Jan. 29, 1997

Japanese researchers isolate novel ACAT inhibitor

Jan. 29, 1997

GHRP mimetics reported by Pfizer for treatment of osteoporosis

Jan. 29, 1997

Hypocholesterolemic activity of raloxifene established in rats

Jan. 28, 1997

GRF analogues developed for growth hormone deficiencies

Jan. 28, 1997

Nisshin Flour Milling claims antidiabetic compounds

Jan. 28, 1997

Therapeutically active PTH derivatives reported by Takeda

Jan. 27, 1997

Phase I trials begin for Fabry's disease

Jan. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...